Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,169
Closed -$1.51M 193
2022
Q4
$1.51M Sell
28,169
-11,544
-29% -$596K 0.31% 44
2022
Q3
$1.83M Buy
+39,713
New +$2.15M 0.58% 44
2022
Q2
Sell
-60,340
Closed -$4.13K 187
2022
Q1
$4.13K Sell
60,340
-46,778
-44% -$3.33M 0.21% 40
2021
Q4
$8.47K Buy
+107,118
New +$8.96M 0.35% 30
2021
Q2
$5.1M Buy
64,710
+14,372
+29% +$1.1M 0.77% 32
2021
Q1
$3.8M Sell
50,338
-76,856
-60% -$5.63M 0.57% 43
2020
Q4
$8.37M Buy
127,194
+2,482
+2% +$145K 1.31% 13
2020
Q3
$6.73M Buy
+124,712
New +$6.85M 1.8% 11
2020
Q1
Sell
-575,553
Closed -$36M 115
2019
Q4
$36M Sell
575,553
-387,862
-40% -$21.9M 5.55% 2
2019
Q3
$48.2M Sell
963,415
-182,707
-16% -$8.63M 6.71% 2
2019
Q2
$55.3M Sell
1,146,122
-77,555
-6% -$3.73M 6.43% 2
2019
Q1
$62.5M Buy
1,223,677
+503,839
+70% +$22.1M 5.17% 4
2018
Q4
$25.9M Buy
+719,838
New +$33.6M 2.21% 7

Other funds holding ENOV

Wexford Capital's ENOV Position: Q1 2023 in Review

Wexford Capital sold out of Enovis (ENOV) in Q1 2023, closing a stake of 28,169 shares — an estimated $1.51M sold.

Wexford Capital first reported a position in ENOV in Q4 2018 and held it in 13 quarters. The position peaked at $62.5M in Q1 2019. 249 funds tracked by Wall St. Rank hold ENOV as of Q1 2023.

  • Wexford Capital reported no remaining Enovis position as of Q1 2023 after selling out during the quarter.
  • Wexford Capital sold 28,169 Enovis shares in Q1 2023, an estimated $1.51M.
  • Wexford Capital first reported a position in Enovis in Q4 2018 and held it in 13 quarters.
  • Wexford Capital's Enovis position peaked at $62.5M in Q1 2019.
  • 249 funds tracked by Wall St. Rank held Enovis as of Q1 2023.

Based on Wexford Capital's 13F filing for Q1 2023, filed 15 May 2023.